CIK 0001719406 · Non-accelerated filer<br>Smaller reporting company
NRX Pharmaceuticals, Inc.
Sign in to watch- Ticker
- NRXP
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 822844431
- Phone
- 484-254-6134
- Business address
- 1201 ORANGE STREET, SUITE 600, WILMINGTON, DE, 19801
- Former names
- Big Rock Partners Acquisition Corp.
- 8-K Event Results of operations · Regulation FD disclosure
- 8-K Event Other events
- 8-K Event Material agreement · New debt or obligation · Unregistered share sale
- 8-K Event Executive or director change · Shareholder vote results · Regulation FD disclosure
- DEF 14A Proxy Proxy Statement
- 8-K Event Executive or director change · Other events
- 8-K Event Results of operations
- 8-K Event Material agreement · New debt or obligation · Unregistered share sale · Bylaws or fiscal year change · Other events
- 8-K Event Delisting notice · Other events
- 8-K Event Agreement ended · Other events
- 8-K Event Executive or director change
- 8-K Event Other events
- 8-K Event Results of operations · Regulation FD disclosure · Other events
- 8-K Event Debt accelerated · Other events
- 10-K/A Report 10-K/A
- 8-K Event Material agreement · Unregistered share sale · Other events
- 8-K Event Other events
- 8-K Event Results of operations
- 10-K Report Annual Report
- 8-K Event Shareholder rights changed · Bylaws or fiscal year change · Regulation FD disclosure
Page 3 of 9 · 166 filings